In-situ observation on the austenite grain growth and martensite transformation in a developed NM500 wear-resistant steel were conducted on a Confocal Laser Scanning High-temperature Microscope (CSLM). Results indicated that the martensite nucleation did not synchronously proceed during quenching process. The selective prenucleation dominated in martensite nucleation, which dividing untransformed austenite into several regions, and resulting in the larger size of fresh martensite. Martensite can not only nucleate at parent austenite grain boundaries, but also nucleate in the preformed martensite laths and twins. Smaller constraint in the martensite growth was achieved in a larger parent austenite grain size, leading to the longer fresh martensite and secondary martensite. Besides, the transformation kinetics of martensite was accelerated in a higher quenching temperature. Moreover, the martensitic laths presented in parallel laths (0~2°) based on the pre-formed lath or distributed in triangle, parallelogram or hexagon with an angle of 60° or 120°. Interestingly, martensitic lath also traversed the unstable new parent austenitic grain boundaries. In addition, the size of austenite grains increased with the quenching temperature, and austenite grains coarsened in a short time at a higher quenching temperature of 1160 ℃. Furthermore, a large amount fine dispersed particles redissolved and ripped at 1160 ℃, resulting in the many large and visible carbonitrides.

Human Epidermal Growth Factor Receptor 2(HER2) is a transmembrane glycoprotein receptor with intracellular tyrosine kinase activity. It is generally considered as a poor prognostic marker. Targeted therapies, such as small molecule tyrosine kinase inhibitors (TKIs), showed limited efficacy in HER2-mutant advanced Non-Small Cell Lung Cancer (NSCLC). In the 2023 NCCN guidelines for NSCLC, Antibody-Drug Conjugate(ADC) Trastuzumab emtansine (T-DM1) is recommended for the treatment of HER2-mutant Lung Cancer (LC). However, this medication is currently not approved in certain regions.So it is necessary to explore alternative treatment options for HER2-mutant NSCLC patients.In our study of a patient with HER2 exon 20ins Lung Adenocarcinoma who had previously failed multiple TKI treatments, we discovered that Sunvozertinib could stabilize the patient's condition, achieving a progression-free survival (PFS) of 87 days. This is a novel finding that may provide new treatment options for HER2 exon 20ins patients who have failed TKI therapy.

This paper presents a piezoresistive pressure sensor with a shield layer for improved stability. Compared with the conventional piezoresistive pressure sensors, p-type piezoresistors are covered by an n-type shield layer, which is formed by ion implantation. The proposed pressure sensors have been successfully fabricated by bulk micromachining techniques. The impact of electrical field on piezoresistors is studied by simulation. The temperature drift of the pressure sensor has been investigated by both simulation and experimental measurement. Characteristics of developed pressure sensors are tested from -40 C to 125 C. A sensitivity of 0.022 mV/V/KPa and a maximum non-linearity of 0.085% FS are measured for the fabricated sensor in a pressure range of 1 MPa. The temperature coefficients of resistance of shielded piezoresistors are found to be smaller than those of un-shielded ones. It is demonstrated that the shield layer is able to reduce the drift caused by electrical field and ambient temperature variation.

An outbreak caused by coronavirus disease 2019 (COVID-19) occurred in Wuhan City, Hubei Province, China, in December 2019. Up to March 2, 2020, at least 80180 cases have been reported. Most of the patients had a history of visiting Hubei Province or contacting with people who had ever stayed in or passed by Hubei Province, or exposed to symptoms. Some patients got infected only from asymptomatic contacts. This study aimed to report the epidemic features and lab identification of a patient confirmed with COVID-19 infection only from asymptomatic contact.